Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Magdalena Zemelka-Wiącek"'
Publikováno v:
Journal of Allergy and Clinical Immunology. 150:1279-1288
Through its disease-modifying potential, immunotherapy is the keystone to curing allergic diseases. Allergen immunotherapy, applied for more than a century, is currently supported by novel modalities such as mAb-based therapies or small molecules tar
Autor:
Wiland, Agata Sebastian, Marta Madej, Paweł Gajdanowicz, Maciej Sebastian, Anna Łuczak, Magdalena Zemelka-Wiącek, Marek Jutel, Piotr
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 18; Pages: 5405
Background: The pathomechanism of primary Sjögren syndrome (pSS) is multifactorial. Many cytokines take part in this process, including interferon. The study aimed to quantify certain cytokines involved in the pathomechanism of primary Sjögren synd
Autor:
Wiland, Agata Sebastian, Marta Madej, Maciej Sebastian, Anna Łuczak, Paweł Gajdanowicz, Magdalena Zemelka-Wiącek, Piotr
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 3
The upregulation of IFN pathways and their stimulated genes is associated with primary Sjögren’s syndrome (pSS). The recent studies also indicate the involvement of interferon γ (IFNγ) in the pathogenesis of pSS. The study aimed to assess the cl
Autor:
Agata Sebastian, Marta Madej, Paweł Gajdanowicz, Maciej Sebastian, Anna Łuczak, Magdalena Zemelka-Wiącek, Marek Jutel, Piotr Wiland
Publikováno v:
Journal of Clinical Medicine. 11:5405
Background: The pathomechanism of primary Sjögren syndrome (pSS) is multifactorial. Many cytokines take part in this process, including interferon. The study aimed to quantify certain cytokines involved in the pathomechanism of primary Sjögren synd
Assessment of autoantibodies in paediatric population with primary immunodeficiencies: a pilot study
Autor:
Karolina Pieniawska-Śmiech, Aleksandra Lewandowicz-Uszyńska, Magdalena Zemelka-Wiacek, Marek Jutel
Publikováno v:
BMC Immunology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background The correlation between primary immunodeficiencies (PIDs) and autoimmunity shows ethnic and geographical diversity. The aim of our study was to accumulate more data in paediatric PID population. Methods 58 children aged 1–17 and
Externí odkaz:
https://doaj.org/article/2be2a4509882408aa23a9d60b4b43512
Autor:
Ewa Winiarska, Monika Chaszczewska-Markowska, Daniel Ghete, Marek Jutel, Magdalena Zemelka-Wiacek
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4724 (2024)
Micro- and nanoplastic particles, including common forms like polyethylene and polystyrene, have been identified as relevant pollutants, potentially causing health problems in living organisms. The mechanisms at the cellular level largely remain to b
Externí odkaz:
https://doaj.org/article/f27f9c566119492ab44521157bf5e2f7
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 68, Pp 955-969 (2014)
The contact hypersensitivity reaction (CHS) to haptens is a classic example of cell-mediated immune response. In the effector phase, two stages can be distinguished: an early component, that appears only 2 hours after subsequent contact with the hapt
Autor:
Magdalena Zemelka-Wiącek, Marta Góralska, Iwona Dorożyńska, Katarzyna Marcińska, Anna Strzępa, Marian Szczepanik, Monika Majewska-Szczepanik
Publikováno v:
Pharmacological Reports. 64:1497-1504
Background Ulcerative colitis (UC) is a chronic inflammatory autoimmune disease with limited treatment modalities. The animal model of colitis induced by treatment with trinitrobenzene sulfonic acid (TNBS-colitis) is commonly used to test new therapi
Autor:
Iwona Dorożyńska, Marta Góralska, Katarzyna Marcińska, Monika Majewska-Szczepanik, Anna Strzępa, Marian Szczepanik, Magdalena Zemelka-Wiącek
Publikováno v:
Pharmacological Reports. 69:585
The authors wish to note an incorrectly listed financial support grant. The National Science Centre grant UMO-2011/01/B/NZ6/00300 was inadvertently listed. The authors regret this error. The correct Acknowledgements read as follows.
Publikováno v:
Journal of Immunological Methods. 439:83